Blood Clot Balance Test

• Evaluating Coagulation Disorders: It reveals any imbalance in coagulation factors and their inhibitors, which may indicate bleeding issues or abnormal blood clotting.
• Assessing Cardiovascular Risk: Elevated levels of plasminogen activator inhibitors can be linked to an increased risk of cardiovascular diseases.
• Monitoring Patients: It is used to track the effectiveness of treatment in patients with blood coagulation disorders or certain medical conditions.
• Providing Additional Information: It serves as an additional diagnostic tool for conditions related to blood clotting.

• Patients with Coagulation Disorders: Such as hemophilia or excessive clotting (hypercoagulability), to evaluate the balance of coagulation factors.
• Patients with a Family History of Heart Disease: To monitor risk factors associated with cardiovascular diseases.
• Individuals Showing Unusual Symptoms of Bleeding or Clotting: Such as excessive bruising or abnormal bleeding.
• Patients Undergoing Anticoagulant Treatment: To monitor the effectiveness of the treatment and adjust dosages.
• Individuals with Chronic Health Conditions: Such as diabetes or obesity, who may have an increased risk of blood clotting problems.
• Patients Planning to Undergo Surgery: To assess the risks of bleeding or clotting during the procedure.

• Excessive Bleeding: Such as unusual bleeding from wounds or excessive bruising.
• Frequent Blood Clots: Like the formation of blood clots in the legs (deep vein thrombosis) or lungs (pulmonary embolism).
• Symptoms Related to Heart Disease: Such as chest pain or shortness of breath, especially if there is a family history of heart disease.
• Changes in Coagulation Ability: For example, unexpected bleeding during or after surgery.
• Symptoms Associated with Infections or Chronic Illnesses: Such as fever or swelling.
• Family History of Blood Coagulation Problems: Which may warrant further evaluation.

Plasminogen Activator Inhibitor-1 (PAI-1): From 0 to 50 nanograms per milliliter (ng/mL).